Maintenance of CMV-specific CD8+ T cell responses and the relationship of IL-27 to IFN-γ levels with aging

Cytokine

Volumn 61, Issue 2, 2013, Pages 485-490

  Shin, Min Sun ^a   Lee, Jin Soo ^a,b   Lee, Naeun ^a   Lee, Won Woo ^a,c   Kim, Sang Hyun ^a,d   Kang, Insoo ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Inha University School of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d Kangwon National University   (South Korea)

Author keywords

Aging; CD8+ T cells; Cytomegalovirus (CMV); Human; IL 27

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; GAMMA INTERFERON; INTERLEUKIN 27; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AGING; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; FLOW CYTOMETRY; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGING; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKINS; LYMPHOCYTE COUNT; MALE; PEPTIDES; PHOSPHOPROTEINS; SPECIES SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA; VIRAL MATRIX PROTEINS;

CYTOMEGALOVIRUS;

EID: 84873104887     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.11.024     Document Type: Article

References (44)

1. Olson M.R., Russ B.E., Doherty P.C., Turner S.J. The role of epigenetics in the acquisition and maintenance of effector function in virus-specific CD8 T cells. IUBMB Life 2010, 62:519-526.
2. Billiau A., Matthys P. Interferon-gamma: a historical perspective. Cytokine Growth Factor Rev 2009, 20:97-113.
3. + T cell effector mechanisms in resistance to infection. Annu Rev Immunol 2000, 18:275-308.
4. Guidotti L.G., Ishikawa T., Hobbs M.V., Matzke B., Schreiber R., Chisari F.V. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996, 4:25-36.
5. Nikolich-Zugich J. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol 2008, 8:512-522.
6. Akbar A.N., Fletcher J.M. Memory T cell homeostasis and senescence during aging. Curr Opin Immunol 2005, 17:480-485.
7. Effros R.B., Cai Z., Linton P.J. CD8 T cells and aging. Crit Rev Immunol 2003, 23:45-64.
8. Khan N., Shariff N., Cobbold M., Bruton R., Ainsworth J.A., Sinclair A.J., et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002, 169:1984-1992.
9. Koch S., Larbi A., Ozcelik D., Solana R., Gouttefangeas C., Attig S., et al. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann NY Acad Sci 2007, 1114:23-35.
10. + T cells contain greatly expanded functional virus-specific memory CTL clones. J Immunol 1999, 162:7569-7577.
11. + T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol 2005, 79:3675-3683.
12. Ouyang Q., Wagner W.M., Zheng W., Wikby A., Remarque E.J., Pawelec G. Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp Gerontol. 2004, 39:607-613.
13. Hadrup S.R., Strindhall J., Kollgaard T., Seremet T., Johansson B., Pawelec G., et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 2006, 176:2645-2653.
14. + T cells against cytomegalovirus in very old subjects. J Immunol 2007, 179:4283-4291.
15. Wojno E.D., Hunter C.A. New directions in the basic and translational biology of interleukin-27. Trends Immunol 2012, 33:91-97.
16. Yoshida H., Nakaya M., Miyazaki Y. Interleukin 27: a double-edged sword for offense and defense. J Leukoc Biol 2009, 86:1295-1303.
17. Cao Y., Doodes P.D., Glant T.T., Finnegan A. IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. J Immunol 2008, 180:922-930.
18. + T lymphocytes and promotes their development into Tc1 cells. Eur J Immunol 2011, 41:47-59.
19. Fitzgerald D.C., Zhang G.X., El-Behi M., Fonseca-Kelly Z., Li H., Yu S., et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 2007, 8:1372-1379.
20. Stumhofer J.S. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 2007, 8:1363-1371.
21. Awasthi A., Carrier Y., Peron J.P., Bettelli E., Kamanaka M., Flavell R.A., et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 2007, 8:1380-1389.
22. Niedbala W., Cai B., Wei X., Patakas A., Leung B.P., McInnes I.B., et al. Interleukin 27 attenuates collagen-induced arthritis. Ann Rheum Dis 2008, 67:1474-1479.
23. Wang J., Wang G., Sun B., Li H., Mu L., Wang Q., et al. Interleukin-27 suppresses experimental autoimmune encephalomyelitis during bone marrow stromal cell treatment. J Autoimmunity 2008, 30:222-229.
24. Liu L., Cao Z., Chen J., Li R., Cao Y., Zhu C., et al. Influenza A Virus Induces Interleukin-27 through Cyclooxygenase-2 and Protein Kinase A Signaling. J Biol Chem 2012, 287:11899-11910.
25. Zhu C., Zhang R., Liu L., Rasool S.T., Mu Y., Sun W., et al. Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro. Clin Immunol 2009, 131:92-97.
26. + T cell responses to influenza vaccine. J Immunol 2004, 173:673-681.
27. + T cells. Mech Ageing Dev 2004, 125:615-618.
28. + T-cell immune responses. Blood 2006, 107:2855-2862.
29. Hwang K.A., Kim H.R., Kang I. Aging and human CD4(+) regulatory T cells. Mech Ageing Dev 2009, 130:509-517.
30. Pawelec G., Derhovanessian E. Role of CMV in immune senescence. Virus Res 2011, 157:175-179.
31. Lee W.W., Shin M.S., Kang Y., Lee N., Jeon S., Kang I. The relationship of cytomegalovirus (CMV) infection with circulatory IFN-alpha levels and IL-7 receptor alpha expression on CD8(+) T cells in human aging. Cytokine 2012, 58:332-335.
32. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007, 128:92-105.
33. Singh T., Newman A.B. Inflammatory markers in population studies of aging. Ageing Res Rev 2011, 10:319-329.
34. Vasto S., Colonna-Romano G., Larbi A., Wikby A., Caruso C., Pawelec G. Role of persistent CMV infection in configuring T cell immunity in the elderly. Immunity Ageing 2007, 4:2.
35. Strandberg T.E., Pitkala K.H., Tilvis R.S. Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease. JAMA 2009, 301:380-382.
36. Roberts E.T., Haan M.N., Dowd J.B., Aiello A.E. Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9years of follow-up. Am J Epidemiol 2010, 172:363-371.
37. Chan G., Bivins-Smith E.R., Smith M.S., Smith P.M., Yurochko A.D. Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. J Immunol 2008, 181:698-711.
38. Owaki T., Asakawa M., Morishima N., Hata K., Fukai F., Matsui M., et al. A role for IL-27 in early regulation of Th1 differentiation. J Immunol 2005, 175:2191-2200.
39. Hisada M., Kamiya S., Fujita K., Belladonna M.L., Aoki T., Koyanagi Y., et al. Potent antitumor activity of interleukin-27. Cancer Res 2004, 64:1152-1156.
40. Chiyo M., Shimozato O., Yu L., Kawamura K., Iizasa T., Fujisawa T., et al. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int J Cancer 2005, 115:437-442.
41. Oniki S., Nagai H., Horikawa T., Furukawa J., Belladonna M.L., Yoshimoto T., et al. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. Cancer Res 2006, 66:6395-6404.
42. * 0201 transgenic mice. J Virol 2004, 78:9093-9104.
43. Greenwell-Wild T., Vazquez N., Jin W., Rangel Z., Munson P.J., Wahl S.M. Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon. Blood 2009, 114:1864-1874.
44. + T cell generation with enhanced granzyme B expression by IL-27. J Immunol 2005, 175:1686-1693.